166 related articles for article (PubMed ID: 20155480)
1. Angiostasis-induced vascular normalization can improve photodynamic therapy.
Nowak-Sliwinska P; Wagnières G; van den Bergh H; Griffioen AW
Cell Mol Life Sci; 2010 May; 67(9):1559-60; author reply 1561. PubMed ID: 20155480
[No Abstract] [Full Text] [Related]
2. Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea.
Weiss A; den Bergh Hv; Griffioen AW; Nowak-Sliwinska P
Biochim Biophys Acta; 2012 Aug; 1826(1):53-70. PubMed ID: 22465396
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor pathway.
Krupitskaya Y; Wakelee H
J Thorac Oncol; 2009 Nov; 4(11 Suppl 3):S1071-3. PubMed ID: 19861922
[No Abstract] [Full Text] [Related]
4. Anti-VEGF therapies in the clinic.
Meadows KL; Hurwitz HI
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028128
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer.
O'Reilly MS
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S64-6. PubMed ID: 17848299
[No Abstract] [Full Text] [Related]
6. Photodynamic therapy in the anti-VEGF era.
Fine HF
Br J Ophthalmol; 2007 Jun; 91(6):707-8. PubMed ID: 17510474
[TBL] [Abstract][Full Text] [Related]
7. Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.
Weiss A; van Beijnum JR; Bonvin D; Jichlinski P; Dyson PJ; Griffioen AW; Nowak-Sliwinska P
J Cell Mol Med; 2014 Mar; 18(3):480-91. PubMed ID: 24450440
[TBL] [Abstract][Full Text] [Related]
8. [Experimental and morphological study of the effect of antiangiogenic therapy on corneal neovessels].
Mamikonian VR; Voevodina TM; Fedorov AA; Budzinskaia MV; Balaian ML
Vestn Oftalmol; 2013; 129(6):45-50. PubMed ID: 24624802
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis -- SMi conference.
Foley P
IDrugs; 2004 Jun; 7(6):551-3. PubMed ID: 15197658
[No Abstract] [Full Text] [Related]
10. Mechanisms of drug resistance to vascular endothelial growth factor (VEGF) inhibitors.
Tavakoli J; Aragon-Ching JB
Anticancer Agents Med Chem; 2010 Oct; 10(8):593-600. PubMed ID: 21182470
[TBL] [Abstract][Full Text] [Related]
11. Malignant hypertension in patients treated with vascular endothelial growth factor inhibitors.
Caro J; Morales E; Gutierrez E; Ruilope LM; Praga M
J Clin Hypertens (Greenwich); 2013 Mar; 15(3):215-6. PubMed ID: 23458595
[No Abstract] [Full Text] [Related]
12. Targeting small molecules in cancer.
Wanebo HJ; Berz D; Mega A
Cancer Treat Res; 2007; 135():239-55. PubMed ID: 17953421
[No Abstract] [Full Text] [Related]
13. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
14. Ten years of anti-vascular endothelial growth factor therapy.
Ferrara N; Adamis AP
Nat Rev Drug Discov; 2016 Jun; 15(6):385-403. PubMed ID: 26775688
[TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis and antiangiogenesis in intraocular tumors].
Macovei L
Oftalmologia; 2010; 54(4):24-6. PubMed ID: 21516858
[TBL] [Abstract][Full Text] [Related]
16. Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better.
Usui-Ouchi A; Friedlander M
J Clin Invest; 2019 Jun; 129(8):3032-3034. PubMed ID: 31232702
[No Abstract] [Full Text] [Related]
17. VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside.
Arjaans M; Schröder CP; Oosting SF; Dafni U; Kleibeuker JE; de Vries EG
Oncotarget; 2016 Apr; 7(16):21247-58. PubMed ID: 26789111
[TBL] [Abstract][Full Text] [Related]
18. [Punctate inner choroidopathy - Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up control].
Weiss S; Winter R; Meyer MW
Ophthalmologe; 2012 Feb; 109(2):149-54. PubMed ID: 22130726
[TBL] [Abstract][Full Text] [Related]
19. Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.
Weiss A; Bonvin D; Berndsen RH; Scherrer E; Wong TJ; Dyson PJ; Griffioen AW; Nowak-Sliwinska P
Sci Rep; 2015 Mar; 5():8990. PubMed ID: 25758612
[TBL] [Abstract][Full Text] [Related]
20. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
